0.83 USD
▼-0.04-4.68%
盘后 0.85 +1.88%
2026-11-20
市值
$1.98M
市盈率
—
EPS
-29.61
股息率
—
52 周区间
0.80 – 16.92
成交量
38.05K
Beta
0.74
目标价
—
52W 低 0.8052W 高 16.92
价格走势
公司简介
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design α-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting ...